HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

epaxal berna

Also Known As:

epaxal

Networked: 8 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Complex Mixtures: 1906
- Biological Products
  - Vaccines: 124365
    - Viral Vaccines: 462
      - Viral Hepatitis Vaccines
        Hepatitis A Vaccines: 365
        epaxal berna: 8

Experts

1.	Herzog, Christian: 3 articles (05/2011 - 12/2006)
2.	Bovier, Patrick A: 2 articles (10/2008 - 08/2008)
3.	Beck, Bernhard R: 1 article (05/2011)
4.	Frösner, Gert: 1 article (05/2011)
5.	Hatz, Christoph: 1 article (05/2011)
6.	Hunt, Marjory: 1 article (05/2011)
7.	van der Ploeg, Robert: 1 article (05/2011)
8.	Abu-Abed, Jaber: 1 article (09/2007)
9.	Amir, Jacob: 1 article (09/2007)
10.	Ashkenazi, Shai: 1 article (09/2007)

Related Diseases

1.	Hepatitis A (Hepatitis, Infectious) 10/01/2008 - "Epaxal: a virosomal vaccine to prevent hepatitis A infection." 01/01/2002 - "Nasalflu is based on the virosomal concept which is registered in the EU as Epaxal Berna, a vaccine against Hepatitis A, and Inflexal Berna V, a subunit influenza vaccine. " 05/01/2011 - "Boosting adult travelers with the virosome-formulated, aluminum-free hepatitis A vaccine Epaxal up to 128 months after a single primary dose confers full protection against hepatitis A, even in travelers aged 50 years and above. " 08/01/1993 - "The inactivated hepatitis A vaccine Epaxal Berna and the hepatitis A immunoglobulin preparation Globuman were products of the Swiss Serum and Vaccine Institute. "
2.	Infections 08/01/2008 - "Epaxal, a virosomal vaccine against hepatitis A virus (HAV) infection, has been in use for nearly 15 years, especially among at-risk adults. " 10/01/2008 - "Epaxal: a virosomal vaccine to prevent hepatitis A infection."
3.	Poliomyelitis (Polio) 09/01/2007 - "Healthy children 12- to 15-month-old were randomized to receive either a pediatric dose (0.25 mL) of Epaxal coadministered with DTPaHibIPV, oral polio vaccine, and measles-mumps-rubella vaccine (n = 109; group A), or Epaxal given alone (n = 105; group B), or Havrix Junior coadministered with DTPaHibIPV, oral polio vaccine, and measles-mumps-rubella vaccine (n = 108; group C). "
4.	Pain (Aches) 12/01/2006 - "Injection site pain categorised as Grade 2 (painful on movement) or Grade 3 (spontaneously painful) (4.7% vs. 22.7%, p=0.0001) was less frequent in the Epaxal group and resolved more quickly (> or =3 days of pain, 8.6% vs. 22.7%, p=0.0001). "
5.	Human Influenza (Influenza) 01/01/2000 - "Biophysical validation of Epaxal Berna, a hepatitis A vaccine adjuvanted with immunopotentiating reconstituted influenza virosomes (IRIV)."

Related Drugs and Biologics

1.	Hepatitis A Vaccines (Hepatitis A Vaccine)
2.	Virosomes
3.	Aluminum
4.	Vaccines
5.	Measles-Mumps-Rubella Vaccine (MMR Vaccine)
6.	Influenza Vaccines (Influenza Vaccine)
7.	Immunoglobulins (Immunoglobulin)